gastrointestinal tract, muscle, and skin, but not the lungs. These findings suggest that at pathophysiological levels, ANF shifts protein out of the circulation in peripheral vascular beds and the lungs and may contribute to pulmonary edema in states such as congestive heart failure. At pharmacological levels, ANF may be protective of the lungs by preventing increased pulmonary albumin escape. (Circulation Research 1990;67:461-468) A trial natriuretic factor (ANF) is elevated in certain disease states such as congestive heart failure, which is associated with both pulmonary and peripheral edema.' Furthermore, some investigators have used ANF in treatment of patients with conditions such as congestive heart failure.2 Because short-term administration of pharmacological doses of ANF results in both enhanced net capillary filtration3-7 and attenuated net capillary absorption,8 it is important to determine whether ANF has a generalized effect on fluid exchange or if its action is confined to certain vascular regions. It is also important to determine whether the effects of ANF on fluid filtration in specific vascular compart-ments differ at pathophysiological and pharmacological infusion rates of ANF. Parkes et a19 recently reported that the decreased plasma volume observed during the first day of long-term infusion of ANF in sheep was associated with an increased rate of escape of`1P-albumin from the circulation. In this present study, we reasoned that an enhanced escape of`1P-albumin from the circulation would be accompanied by increased fluid filtration and that if the escape rate of`251-albumin could be quantitated in specific organs, information with regard to the regional distribution of ANF's action on capillary fluid shift could be obtained. We hypothesized that ANF may contribute to edema formation at pathophysiological levels by enhancing albumin escape from the vasculature in both the pulmonary and peripheral vascular beds but may be protective of the lung at pharmacological levels by preventing increased pulmonary albumin escape by decreasing venous return. 7 Therefore, the present study was performed in splenectomized, nephrectomized, anesthetized rats to determine the total-body and organ-specific albumin escape rates in rats infused (1 -LVHct)/blood "`I activity concentration; and BV= RCV+PV. The whole-body F cell ratio, which represents the ratio of whole-body hematocrit to LVHct, was determined by (RCV/BV)/LVHct. For subsequent blood samples, the following formulas were used: BV=[(51Cr activity injected-cumulative sampling loss of 51Cr activity)/blood 51Cr activity concentration]/F cells; RCV=RCV measured during the first sample-RCV lost through sampling. RCV lost through sampling=MCr activity lost through sampling/! Cr activity per milliliter RCV; 51Cr activity per milliliter RCV=`Cr activity injected/RCV measured during first sample; PV=BV-RCV.
Organ and Tissue Blood Volume
Corrected 51Cr and '`'I radioactivities for organs and tissues were determined as described above. Organ blood volume (OBV) was calculated according to OBV=(organ 51Cr activity/blood 51Cr activity concentration)/organ F cells, where blood 51Cr activity represents the blood sample taken immediately before the rat was frozen and organ F cells is the ratio of organ hematocrit to LVHct.
The organ F cell ratios were determined in separate groups of rats as follows. Male Sprague-Dawley rats weighing 312-370 g were anesthetized and surgically prepared as described above. However, in this series, the infusion of vehicle (n=3) or ANF (n=2; 0.5 ,gg min-1 * kg-') (at the same rates and duration described above) was commenced before labeled erythrocytes and albumin were injected. At 10 and 5 minutes before blood samples were drawn and the rats were frozen,`Cr-erythrocytes and "'I-albumin were injected, respectively, as described above. Therefore, unlike the experiments described above, whereby 1251-albumin was allowed to escape from the circulation for 2 hours before the rats were frozen, the rats were frozen in liquid nitrogen at 5 minutes after injection of I-albumin. Based on the whole-body escape rate of 5I-albumin from the circulation as measured in the experiments described above, it was estimated that approximately 1% of the injected`251-albumin would have crossed the capillaries into the tissues by 5 minutes after injection (see "Results"). Therefore, except for the liver, whose sinusoids are highly permeable to albumin,12 the level of 125I radioactivity measured in each organ at 5 minutes after injection of 251-albumin provided an estimate of the organ plasma volume, while the organ 51Cr activity was a measure of organ erythrocyte volume. Each organ hematocrit was determined according to standard relations (see "Appendix"), which reduced algebraically to the following formula:
where ratio is the ratio between 51Cr activity/1251 activity in each organ and 51Cr activity/"25I activity in blood, that is, (Cr/I) organ/(Cr/I) blood. This formula, applied to an example of a set of data given by in the tissues in whole organs was expressed as tissuè I activity/total 125I activity detected in all organs studiedx 100. Total`I activity detected in all organs represented the activity in blood and tissue. Total skeletal muscle and skin masses were determined as 47% and 20% body weight, respectively. These latter values were determined by completely dissecting one rat weighing 350 g and boiling the muscle from the bones to determine skeletal weight; they compare reasonably well to values determined from previously reported data.14 ANF levels were determined in a separate group of nephrectomized, splenectomized, anesthetized rats after saline infusion or ANF infusion at the same rates and concentrations used in the albumin escape studies. Approximately 2.5 ml blood was obtained after 2 hours of infusion. ANF concentrations were determined by radioimmunoassay after extraction on a C18 Sep-Pak cartridge (Millipore Corp., Milford, Mass.) and elution with 1 ml of 60% acetonitrile in 0.2% ammonium acetate. 15 The interassay and intra-assay coefficients of variation were 15% and 6%, respectively. Recovery was 75%.
Calculations The total-body albumin escape rate did not change at the lowest levels of ANF infusion but increased by 56% at an ANF infusion rate of 0.1 jig * min`-* kg`and by 127% at an ANF infusion rate of 0.5 ,g * min-1 kg1 (Figure 2 ). ANF selectively enhanced the organ albumin escape rate only at the two highest infusion rates of ANF as shown in Figure 3 . At an ANF infusion rate of 0.1 gg min-1 * kg-1, the albumin escape rate was increased in the heart, lung, gastrointestinal tract, and muscle. At an infusion rate of 0.5 ,ug * min`* kg-', the ANF Infusion Rate, pg/kg/mln FIGURE 2. Rate at which l2SI-albumin escapedfrom the total circulation over a 2-hour period in the groups of rats featured in Figure 1 . ANF, atrial natriuretic factor. accumulation is measured, as shown in Figure 4 , muscle albumin escape accounts for the highest percentage of albumin escape. Organ plasma volume is illustrated in Figure 5 . Plasma volume significantly decreased in heart and muscle at an ANF infusion rate of 0.1 gg* min`f . kg`and decreased in heart and lung at an ANF infusion rate of 0.5 ,gg min`f . kg-'. Organ blood volume as a percentage of total blood volume is shown in Table 2 . No change in blood volume distribution was observed at any dose of ANF infusion.
Discussion
To obtain direct evidence regarding the mechanisms by which ANF shifts fluid and protein out of the vascular system will likely require studies of regional or local microcirculations. Therefore, this present study was aimed at determining the specific organs in which ANF enhances protein transfer. ANF was infused in anesthetized, anephric, and splenectomized rats for 2 hours at physiological, pathophysiological, and pharmacological doses. Plasma volume decreased, while the rate of escape of 1251-albumin from the circulation increased at ANF infusion rates of 0.1 and 0.5 jig. min-l* kg`. At a pathophysiological ANF infusion rate (0.1 ,jg. min-l* kg-'), labeled albumin escaped mainly into the muscle and gastrointestinal tract but also significantly increased in the lung. At pharmacological levels of ANF infusion (0.5 ,gg min`' kg-'), the greatest increase in escaped albumin accumulated in the tissues of the skeletal muscle, skin, and gastrointestinal tract, but not in the lungs. A similar increase in the 1251-albumin content of skeletal muscle after ANF infusion was previously reported by Winquist et a116 in conscious rats. These findings suggest that the action of ANF to shift protein out of the circulation is not selective for various peripheral vascular beds. At high ANF infusion rates, it is likely that the lungs are protected by decreases in pulmonary pressures, as suggested by the decrease in central venous pressure.
Irrespective of the mechanism by which ANF increased the transmicrocirculatory movement of albumin, it is reasonable to assume that the increased tissue content of`2I-albumin was attended by some increase in tissue fluid as well. For instance, if ANF facilitated the transmicrocirculatory movement of 12I-albumin by diffusion or vesicular exchange, an enhancement of fluid filtration would likely occur because of the changes in microcirculatory oncotic forces. Another possibility is that ANF altered the microcirculatory hydrostatic forces in favor of filtration, and the increased transport of albumin reflected transmicrocirculatory albumin flux that was directly ORGAN ALBUMIN ESCAPE RATES preliminary studies for the three rats receiving vehicle were similar to those in the two rats receiving a pharmacological dose of ANF. In the main study, the average whole-body F cell ratio was similar in the vehicle and ANF groups ( Table 1 ). These considerations support the assumption that ANF did not change the F cell ratio and that the data obtained in the preliminary experiments could be applied to all groups in the main study.
Circulating ANF levels in rats infused with 0.1
,ggmin-lkg-1 were 1,232+199 pg/ml. These levels are within the range of ANF levels previously reported from this laboratory for rats with experimental heart failure.15 It is interesting that at ANF levels seen in heart failure, albumin escape is enhanced in the lung, whereas at pharmacological levels of ANF, the lung is protected from albumin escape. Although there may be differential effects of ANF on the peripheral and pulmonary vasculature, this is unlikely because no differences are seen at the lower infusion rates. It is most likely that the differential effect of ANF on the pulmonary vasculature and the peripheral circulation noted at pharmacological infusion rates of ANF are due to the overall hemodynamic effects of ANF. 24 showing that ANF does not promote albumin escape in the lungs at pharmacological infusion doses. Unlike the previous study, however, we have also evaluated organ-specific albumin escape rates at pathophysiological ANF infusion doses and found that ANF does enhance albumin escape at these levels. Finally, although not a primary aim in this study, the data confirmed earlier findings in rats with intact kidneys and spleens that ANF did not cause a major redistribution of blood volume to the splanchnic region,10 as shown in Table 2 . The splanchnic circulation contains the greatest vascular capacitance of the circulation,25 and dilation of the splanchnic capacitance vessels would be expected to cause a redistribution of blood volume into these organs, as was observed in ganglionic blocked rats.'0 The lack of such an effect by ANF supports our contention that ANF is not a potent dilator of capacitance vessels7 and does not lower cardiac output via a redistribution of blood volume.
OPV=organ 1251 activity/125I activity per milliliter plasma (A-4)
OBV=ORCV+OPV (A-5)
OHct= ORCV/OBV (A-6)
